Axon Enterprise (AXON) shares experienced significant volatility, falling 49.9% between August and November 2026, with the steepest decline occurring after the release of its fiscal Q3 2026 report. The stock dropped 18.2% on November 6 following management's announcement that it would borrow $1.0 billion via convertible notes to fund strategic investments and inventory buildup. This capital raise marked a shift in the company's balance sheet, moving from a net cash position to one carrying more debt than cash. Management revised its financial outlook for fiscal year 2026, guiding free cash flow between $350 million and $400 million, down from a prior target of $450 million. A substantial portion of the borrowed funds is allocated to a $1.2 billion investment in Skydio, a drone manufacturer, which will be paid for using a mix of cash and stock. Additionally, Axon adjusted its revenue recognition timing, moving drone revenue associated with three federal Dedrone deployments out of 2026, representing nearly 500 basis points of expected growth. Despite the stock price decline, Axon's software business continues to expand rapidly, with Software and Services revenue rising 43% year-over-year to $437 million in Q3. However, the company faces valuation challenges, trading at 96.3 times reported earnings compared to 21.9 for the S&P 500, while operating margins remain low at 2.0% over the trailing twelve months versus 19.0% for the broader index. Revenue growth remains robust overall, with total revenue increasing 33.6% year-over-year through September 2026, though TASER sales declined modestly due to lower demand for the TASER 7 model. Analysts and investors are closely watching the software segment's performance as a key indicator of future profitability, with fiscal Q4 2026 results expected in February 2027.